Single Nucleotide Polymorphisms (SNPs) and Their Role in Reproductive Health: A Genetic Analysis
Keywords:
Single Nucleotide Polymorphism, Infertility, MthfrAbstract
Infertility is considered a disease with a high prevalence and a primary genetic factor, as single-nucleotide polymorphisms (SNPs) in metabolic and hormonal genes impair fertility. Our current study aimed to determine the impact of single-nucleotide polymorphisms (SNPs) on reproductive health in a group of 68 infertile patients (34 couples). Based on the study's methodological design, a cross-sectional study was conducted on 68 patients in different hospitals in Iraq, during a follow-up period of 12 months. Clinical data were recorded, including semen parameters, hormonal profiles, history of pregnancy loss, and genotype distributions. The study results showed a strong association between the FSHR rs6166 polymorphism and decreased ovarian reserve. It was observed that female patients who received the G allele vaccine had lower AFC levels (6.3 ± 2.1 vs. 14.5 ± 4.2), which constituted 83.3% of women with poor ovarian response, while the MTHFR rs1801133 TT genotype was associated with lower semen quality and also lower sperm concentration (15.4 ± 12.1 vs. 38.2 ± 18.5 ml/ml) in males. Furthermore, the ESR1 rs2234693 TT genotype was associated with higher baseline FSH levels (9.2 ± 2.8 vs. 6.8 ± 1.5 mIU/mL, p=0.041), which may indicate a higher frequency of F5 Leiden (rs6025) mutation carriers in women with recurrent pregnancy loss (21.4% vs. 5.0%). This study concludes that single-nucleotide polymorphisms (SNPs) in FSHR and MTHFR are strongly associated with ovarian response and sperm quality in infertile patients, and that genetic testing for these variants could provide valuable diagnostic information.
References
1. Barratt C.L., Björndahl L., De Jonge C.J., Lamb D.J., Martini F.O., McLachlan R., Oates R.D., van der Poel S., John B.S., Sigman M. The diagnosis of male infertility: An analysis of the evidence to support the development of global WHO guidance—Challenges and future research opportunities. Hum. Reprod. Update. 2017;23:660–680.
2. Agarwal A., Baskaran S., Parekh N., Cho C.-L., Henkel R., Vij S., Arafa M., Selvam M.K.P., Shah R. Male infertility. Lancet. 2021;397:319–333.
3. World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen. World Health Organization; Geneva, Switzerland: 2021.
4. A. Male infertility: Evidences, risk factors, causes, diagnosis, and management in humans. Ann. Clin. Lab. Res. 2017;5:188.
5. Oud M.S., Volozonoka L., Smits R.M., Vissers L.E., Ramos L., Veltman J.A. A systematic review and standardized clinical validity assessment of male infertility genes. Hum. Reprod. 2019;34:932–941.
6. A.A., Al K., Motair W., Bawa A.M. Secondary infertility and the aging male, overview. Cent. Eur. J. Urol. 2014;67:184.
7. Tournaye H., Krausz C., Oates R.D. Concepts in diagnosis and therapy for male reproductive impairment. Lancet Diabetes Endocrinol. 2017;5:554–564.
8. Nowicka-Bauer K., Lepczynski A., Ozgo M., Kamieniczna M., Fraczek M., Stanski L., Olszewska M., Malcher A., Skrzypczak W., Kurpisz M. Sperm mitochondrial dysfunction and oxidative stress as possible reasons for isolated asthenozoospermia. J. Physiol. Pharmacol. 2018;69:403–417.
9. Tüttelmann F., Ruckert C., Röpke A. Disorders of spermatogenesis: Perspectives for novel genetic diagnostics after 20 years of unchanged routine. Med. Genet. 2018;30:12–20.
10. Darley-Usmar V. The powerhouse takes control of the cell: the role of mitochondria in signal transduction. Free. Radic. Biol. Med. 2004;37:753–754.
11. Shamsi M.B., Kumar R., Bhatt A., Bamezai R., Kumar R., Gupta N.P., Das T., Dada R. Mitochondrial DNA mutations in etiopathogenesis of male infertility. Indian J. Urol. 2008;24:150–154.
12. Alexeyev M., Shokolenko I., Wilson G., LeDoux S. The maintenance of mitochondrial DNA integrity—Critical analysis and update. Cold Spring Harb. Perspect. Biol. 2013;5:a012641.
13. Baklouti-Gargouri S., Ghorbel M., Mahmoud A.B., Mkaouar-Rebai E., Cherif M., Chakroun N., Sellami A., Fakhfakh F., Ammar-Keskes L. Mitochondrial DNA mutations and polymorphisms in asthenospermic infertile men. Mol. Biol. Rep. 2013;40:4705–4712.
14. Holyoake A., McHugh P., Wu M., O’Carroll S., Benny P., Sin I., Sin F. High incidence of single nucleotide substitutions in the mitochondrial genome is associated with poor semen parameters in men. Int. J. Androl. 2001;24:175–182.
15. St John J.C., Sakkas D., Barratt C.L. A role for mitochondrial DNA and sperm survival. J. Androl. 2000;21:189–199.
16. Spiropoulos J., Turnbull D.M., Chinnery P.F. Can mitochondrial DNA mutations cause sperm dysfunction? MHR Basic Sci. Reprod. Med. 2002;8:719–721.
17. Smeitink J., van den Heuvel L., DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat. Rev. Genet. 2001;2:342–352.
18. Karimian M., Babaei F. Large-scale mtDNA deletions as genetic biomarkers for susceptibility to male infertility: A systematic review and meta-analysis. Int. J. Biol. Macromol. 2020;158:85–93.
19. Kao S.-H., Chao H.-T., Wei Y.-H. Multiple deletions of mitochondrial DNA are associated with the decline of motility and fertility of human spermatozoa. Mol. Hum. Reprod. 1998;4:657–666.
20. Bahrehmand Namaghi I., Vaziri H. Sperm mitochondrial DNA deletion in Iranian infertiles with asthenozoospermia. Andrologia. 2017;49:e12627.
